05:04 PM EDT, 08/09/2024 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on August 07, 2024, sold 50,000 shares in Recursion Pharmaceuticals ( RXRX ) for $343,000. Following the Form 4 filing with the SEC, Gibson has control over a total of 758,738 shares of the company, with 758,738 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183024000122/xslF345X03/wk-form4_1723236963.xml

Price: 6.34, Change: +0.05, Percent Change: +0.79